ARCHIVES

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Cancer Caused By Environmental Exposure “Grossly Underestimated,” Cancer Panel Says.

May 7, 2010

ASCO: NCI Authorities Still Important

June 11, 2010

Interview: Joseph Jacobs Claims “Political Extortion” By The “Harkinites”

October 14, 1994

Radiation Doesn’t Add Benefit For Early Endometrial Cancer

June 29, 2007